Neurometrix Inc (NASDAQ:NURO)

CAPS Rating: 1 out of 5

The Company designs, develops and sells proprietary medical devices used to help physicians diagnose neuropathies and neurovascular disease.

Results 1 - 13 of 13

Recs

0
Member Avatar Teacherman1 (57.77) Submitted: 7/11/2014 8:42:32 PM : Outperform Start Price: $2.22 NURO Score: -20.56

No meaningful data until after the conference call in a couple of weeks, but a company with a good position in the treatment of chronic pain with wearable technology. They just got approval for an over-the-counter version of their prescription chronic pain treatment device SENSUS. The over-the counter version has a planned launch for 2015.

They focus on the treatment of diabetic neuropathies, (which afflicts millions of people world wide), without the use of drugs.

Due in part to my own chronic pain problems (from a spine problem), brought into focus with my wife's recent pain from hip replacement surgery, I am very aware of how welcome such a device would be.

I am actually in at $2.15, with a fairly small position, so I can hold and watch without too much concern.

Do your own DD, but if you are into semi-speculation, then this may be one for you.

Just my opinion and worth exactly what I am charging for it.

Recs

0
Member Avatar Burgermyster321 (45.85) Submitted: 12/27/2010 12:00:59 PM : Outperform Start Price: $0.69 NURO Score: +97.68

Good technicals and Good value.

Recs

0
Member Avatar utosweet (27.49) Submitted: 2/3/2008 12:58:06 PM : Underperform Start Price: $11.10 NURO Score: +129.48

This is a junk stock....Only a home run play,you know...a do or die.But,time is on its side...I will see !

Recs

0
Member Avatar STARSUPER8 (84.14) Submitted: 7/17/2007 5:05:39 PM : Outperform Start Price: $8.32 NURO Score: -111.42

IIOTTMCO

Recs

0
Member Avatar 2099ep (72.86) Submitted: 3/27/2007 2:59:49 PM : Outperform Start Price: $9.39 NURO Score: -125.03

Trading low at the moment - got to expect an upswing soon - fundamentals are too good to keep it low. NURO should thrive along with most healthcare stocks

Recs

0
Member Avatar mnsmartmoney (< 20) Submitted: 3/8/2007 6:52:17 PM : Outperform Start Price: $11.86 NURO Score: -127.56

This one is way oversold and due for some good news. IMO they look like they could be bought out with where the price is now. From my own dd I see their products as viable and legitimate. I look for the whole reimbursement problem to resolve itself. Like they say "Buy when there is blood on the streets". Now is the time to jump in on this one.

Recs

0
Member Avatar Whitegroup (64.61) Submitted: 11/26/2006 9:16:33 AM : Outperform Start Price: $18.91 NURO Score: -137.59

If they get the green light stock is going up huge

Recs

0
Member Avatar halmcneely (37.44) Submitted: 11/23/2006 3:37:47 PM : Outperform Start Price: $17.69 NURO Score: -136.91

Promising earnings growth; in formative stage. Can provide another extra charge for physicians using tech help,

Recs

0
Member Avatar glencoburn (95.13) Submitted: 10/30/2006 8:24:44 PM : Underperform Start Price: $16.29 NURO Score: +138.34

Headed for their demise.

Recs

0
Member Avatar brightidea2006 (82.91) Submitted: 10/20/2006 11:44:15 AM : Outperform Start Price: $19.57 NURO Score: -141.70

great clinical adoption of neuro test and short thesis of reimbursement cuts way overplayed

Recs

0
Member Avatar BlackDog56 (< 20) Submitted: 10/6/2006 9:02:08 AM : Outperform Start Price: $18.00 NURO Score: -142.92

Over reaction to potentially bad news drove this stock lower than warranted. Should rebound to the 30's by early 2007.

Recs

0
Member Avatar elaborio (74.67) Submitted: 9/15/2006 6:31:57 PM : Underperform Start Price: $21.14 NURO Score: +146.90

FBI, report investigation..... Not good!!!!

Recs

0
Member Avatar beelzy10 (22.24) Submitted: 9/14/2006 10:01:41 PM : Outperform Start Price: $21.23 NURO Score: -147.20

medical stock , neurological

Results 1 - 13 of 13

Featured Broker Partners


Advertisement